GO:0048692 negative regulation of axon extension involved in regeneration: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048692 describes any process that stops, prevents, or reduces the frequency, rate or extent of axon extension involved in regeneration.
• The term is a biological_process child of negative regulation of axon extension and is distinct from developmental axon guidance.
• RhoA and Rac1 GTPase signaling is a central brake on regenerative axon extension, and dominant-negative RhoA/Rac1 enhances sciatic nerve regeneration in vivo.
• Nogo-A and its receptor complex, including LINGO-1, restrict neurite extension and oligodendrocyte precursor differentiation through Rho GTPase-dependent mechanisms [3,4].
• Neurotrophin signaling through ACK1 and transcriptional corepressors such as TPA-inducible sequence 7 (TIS7) modulate adult axon growth and branching [6,7].
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to causally test candidate negative regulators of regenerative axon extension.
Description
GO:0048692, negative regulation of axon extension involved in regeneration, is a Gene Ontology biological_process term that captures the active cellular programs that restrain or terminate axon outgrowth during regeneration. In contrast to positive regulators that promote regrowth after injury, this term specifically covers inhibitory mechanisms that reduce the frequency, rate, or extent of regenerative axon extension. Understanding these brakes is clinically important because adult mammalian central nervous system axons regenerate poorly, and relieving inhibition is a major therapeutic strategy [1,3]. The term is mechanistically linked to Rho GTPase signaling, myelin-associated inhibitors, neurotrophin signaling, and transcriptional control of growth-associated programs [1,3,4,6,7]. Researchers studying axon regeneration therefore need precise tools to identify and manipulate the genes that execute this negative regulation.
negative regulation of axon extension involved in regeneration At A Glance
| GO ID | GO:0048692 |
|---|---|
| GO term | negative regulation of axon extension involved in regeneration |
| Ontology | biological_process |
| Synonym | down regulation of axon extension involved in regeneration; down-regulation of axon extension involved in regeneration; downregulation of axon extension involved in regeneration; inhibition of axon extension involved in regeneration |
| Major function | Stops, prevents, or reduces the frequency, rate or extent of axon extension involved in regeneration. |
| Related process | Axon extension involved in regeneration; negative regulation of axon extension; Rho GTPase signal transduction [1,3]. |
| Key molecular players | RhoA, Rac1, Nogo-A, LINGO-1, ACK1, TIS7 [1,3,4,6,7]. |
| Disease relevance | Impaired CNS regeneration, spinal cord injury, neurodegenerative conditions [1,3,4]. |
| Research methods | CRISPR KO/point mutation/knock-in/overexpression, neurite outgrowth assays, Rho GTPase activity assays [1,3,6,7]. |
What Is GO:0048692?
In our own words, GO:0048692 refers to any biological process that stops, prevents, or reduces the frequency, rate, or extent of axon extension specifically in the context of regeneration. It is not a general axon guidance term; it applies to the active suppression of regrowth after injury or in regenerative contexts. The term encompasses signaling events, cytoskeletal changes, and transcriptional programs that limit regenerative axon elongation [1,3,6,7].
Why Is negative regulation of axon extension involved in regeneration Important in Cell Biology?
GO:0048692 matters because the failure of axon regeneration after injury or in neurodegenerative disease is often due to active inhibitory signaling rather than a simple absence of growth capacity [1,3]. Identifying the negative regulators that execute this term provides therapeutic targets to unlock regenerative growth [1,3,4].
• Defines the molecular brakes that limit axon regrowth after spinal cord injury or peripheral nerve damage.
• RhoA/Rac1 inhibition is sufficient to enhance sciatic nerve regeneration in vivo.
• Myelin-associated inhibitors such as Nogo-A signal through LINGO-1 and Rho GTPases to restrict neurite extension [3,4].
• Neurotrophin signaling components such as ACK1 influence neuronal extension and branching.
• Transcriptional corepressors such as TIS7 regulate adult axon growth via CRABP-II expression.
• Provides a framework for interpreting CRISPR screens aimed at discovering regeneration inhibitors.
• Links cytoskeletal dynamics to regenerative failure in the adult CNS [1,3].
• Supports development of combinatorial therapies that simultaneously relieve multiple inhibitory pathways [1,3].
• Helps distinguish negative regulation of regenerative extension from developmental axon guidance.
• Guides selection of gene targets for knockout or point-mutation modeling in neurons [1,3,6,7].
What Happens During negative regulation of axon extension involved in regeneration?
Initiation by inhibitory ligands and receptors
In simple terms: Inhibitory cues bind receptors on the growth cone and start a brake signal.
Negative regulation of regenerative axon extension is initiated when inhibitory ligands such as Nogo-A engage receptor complexes that include LINGO-1, leading to activation of intracellular signaling that restrains neurite extension [3,4]. Nogo-A can also regulate neurite fasciculation, branching, and extension in the developing nervous system, indicating that these inhibitory mechanisms are context-dependent.
Rho GTPase activation and cytoskeletal restraint
In simple terms: Rho GTPases act like molecular switches that tighten the cytoskeleton and stop the axon from growing.
Downstream of inhibitory receptors, RhoA and Rac1 GTPases are key effectors that reduce regenerative axon extension [1,3]. Expression of dominant-negative RhoA and Rac1 enhances sciatic nerve regeneration, demonstrating that these GTPases are causal brakes on regenerative growth in vivo. LINGO-1 and Rho GTPases are also involved in Nogo-A-regulated differentiation of oligodendrocyte precursor cells, linking inhibitory signaling to glial biology.
Neurotrophin and kinase signaling modulation
In simple terms: Growth factor signals can either promote or restrain extension depending on which kinases are engaged.
The tyrosine kinase ACK1 plays a role in neurotrophin signaling and in neuronal extension and branching, showing that kinase pathways can modulate the balance between growth and restraint. This indicates that negative regulation of regenerative axon extension is not a single linear pathway but a network of competing signals.
Transcriptional control of growth programs
In simple terms: Long-lasting brakes on axon growth are often enforced by changing which genes are turned on or off.
The transcriptional corepressor TPA-inducible sequence 7 (TIS7) regulates adult axon growth through cellular retinoic acid binding protein II (CRABP-II) expression, providing a transcriptional mechanism for negative regulation of regenerative axon extension. This highlights that sustained inhibition of regeneration can be maintained at the level of gene expression.
Modulation by small molecules and nutrients
In simple terms: Vitamins and small molecules can influence how neurons respond in degeneration models.
Neurotropic B vitamins, vitamin D3, and alpha-lipoic acid have been evaluated in in vitro models of neurodegeneration, indicating that nutritional and small-molecule factors can modulate neuronal viability and outgrowth programs relevant to regenerative inhibition. Achyranthes bidentata polypeptide k has also been shown to affect Schwann cell proliferation, which indirectly influences the regenerative environment.
Key Genes Involved in GO:0048692 negative regulation of axon extension involved in regeneration
The following genes and proteins have been experimentally linked to negative regulation of axon extension involved in regeneration or to closely related regenerative axon growth mechanisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RhoA | GTPase that restrains regenerative axon extension | Dominant-negative RhoA enhances sciatic nerve regeneration. |
| Rac1 | GTPase involved in inhibitory signaling and regeneration | Dominant-negative Rac1 enhances sciatic nerve regeneration. |
| Nogo-A | Myelin-associated inhibitor of neurite extension | Regulates neurite fasciculation, branching, and extension. |
| LINGO-1 | Co-receptor for Nogo-A signaling | Involved in Nogo-A-regulated oligodendrocyte precursor differentiation via Rho GTPases. |
| ACK1 | Tyrosine kinase in neurotrophin signaling | Regulates neuronal extension and branching. |
| TIS7 | Transcriptional corepressor | Regulates adult axon growth through CRABP-II expression. |
| CRABP-II | Retinoic acid binding protein | Downstream effector of TIS7 in adult axon growth. |
| Schwann cell factors | Support regenerative environment in peripheral nerve | Achyranthes bidentata polypeptide k affects Schwann cell proliferation. |
| Neurotrophin receptors | Mediate growth factor signaling | Modulate extension and branching via ACK1. |
| Rho GTPase effectors | Cytoskeletal regulators | Downstream of LINGO-1 and Nogo-A. |
| Myelin-associated inhibitors | Restrict regenerative growth | Targets for relieving negative regulation [1,3,4]. |
| Retinoic acid signaling components | Transcriptional regulation of growth | Linked to TIS7/CRABP-II axis. |
| B-vitamin responsive pathways | Modulate neurodegeneration models | Evaluated in in vitro neurodegeneration. |
| Alpha-lipoic acid responsive pathways | Antioxidant and neuroprotective | Studied in in vitro neurodegeneration models. |
| Vitamin D3 responsive pathways | Neurotropic and neuroprotective | Studied in in vitro neurodegeneration models. |
| ACK1 substrates | Cytoskeletal and signaling effectors | Implicated in neuronal extension and branching. |
How Is negative regulation of axon extension involved in regeneration Regulated?
Negative regulation of axon extension involved in regeneration is itself regulated at multiple levels. Rho GTPase activity is controlled by guanine nucleotide exchange factors and GTPase-activating proteins downstream of inhibitory receptors such as Nogo-A and LINGO-1 [1,3]. Neurotrophin signaling through ACK1 provides an additional layer of kinase-dependent regulation of extension and branching. Transcriptional control by TIS7 and CRABP-II enforces longer-lasting changes in growth capacity. Environmental and nutritional factors, including neurotropic B vitamins, vitamin D3, and alpha-lipoic acid, can also modulate neuronal behavior in degeneration models.
negative regulation of axon extension involved in regeneration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RhoA | Spinal cord injury, peripheral nerve regeneration | Dominant-negative RhoA overexpression in sciatic nerve injury models. |
| Rac1 | Peripheral nerve regeneration | Dominant-negative Rac1 overexpression in sciatic nerve injury models. |
| Nogo-A | CNS regenerative failure | Nogo-A knockout or knockdown in neuronal cultures and injury models. |
| LINGO-1 | Oligodendrocyte precursor differentiation, CNS repair | LINGO-1 knockout or knockdown in oligodendrocyte precursor cells. |
| TIS7 | Adult axon growth regulation | TIS7 knockout or overexpression in adult neurons. |
Spinal cord injury and CNS regenerative failure
After spinal cord injury, myelin-associated inhibitors such as Nogo-A signal through LINGO-1 and Rho GTPases to restrict axon extension, contributing to regenerative failure [1,3,4]. Targeting RhoA and Rac1 with dominant-negative constructs enhances peripheral nerve regeneration, supporting the therapeutic potential of relieving this negative regulation.
Neurodegenerative conditions
In in vitro models of neurodegeneration, neurotropic B vitamins, vitamin D3, and alpha-lipoic acid have been tested for their effects on neuronal viability and outgrowth, highlighting the relevance of negative regulation of axon extension to neurodegenerative contexts. ACK1-dependent neurotrophin signaling also influences neuronal extension and branching, which may be dysregulated in disease.
Peripheral nerve regeneration and Schwann cell biology
Schwann cells support peripheral nerve regeneration, and factors such as Achyranthes bidentata polypeptide k can influence Schwann cell proliferation, indirectly modulating the regenerative environment. Dominant-negative RhoA and Rac1 expression enhances sciatic nerve regeneration, directly linking negative regulation of axon extension to peripheral nerve repair.
From negative regulation of axon extension involved in regeneration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of RhoA enhance regenerative axon extension? | CRISPR knockout of RhoA in primary neurons or in vivo nerve injury models. |
| Does a point mutation in Rac1 alter GTPase activity and regeneration? | CRISPR point-mutation knock-in of Rac1 in neuronal cells. |
| Does LINGO-1 mediate Nogo-A-dependent inhibition? | LINGO-1 knockout or knockdown in oligodendrocyte precursor cells. |
| Does ACK1 kinase activity regulate neuronal extension? | ACK1 knockout or kinase-dead knock-in in neurons. |
| Does TIS7 repress adult axon growth via CRABP-II? | TIS7 overexpression or knockout with CRABP-II readout. |
| Can small molecules relieve negative regulation? | In vitro neurodegeneration models treated with B vitamins, vitamin D3, or alpha-lipoic acid. |
How to Study the negative regulation of axon extension involved in regeneration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Neurite outgrowth assay | Frequency, rate, and extent of axon extension | Testing negative regulators in cultured neurons [1,3,6]. |
| Rho GTPase activity assay | RhoA and Rac1 activation state | Assessing inhibitory signaling downstream of Nogo-A/LINGO-1 [1,3]. |
| RNA-seq | Transcriptional changes | Identifying TIS7/CRABP-II-dependent growth programs. |
| Immunofluorescence imaging | Growth cone morphology and axon length | Visualizing regenerative extension in vitro [3,4]. |
| Sciatic nerve injury model | In vivo regeneration capacity | Testing dominant-negative RhoA/Rac1. |
| Schwann cell proliferation assay | Glial support for regeneration | Evaluating Achyranthes bidentata polypeptide k effects. |
| Neurodegeneration in vitro model | Neuronal viability and outgrowth | Testing B vitamins, vitamin D3, and alpha-lipoic acid. |
| Kinase activity assay | ACK1 signaling | Linking neurotrophin signaling to extension and branching. |
Neurite outgrowth and regeneration assays
Neurite outgrowth assays are used to measure the frequency, rate, and extent of axon extension in cultured neurons, allowing direct assessment of negative regulation [1,3,6]. These assays can be combined with inhibitory ligands such as Nogo-A to test whether candidate genes mediate inhibition [3,4].
Rho GTPase activity assays
RhoA and Rac1 activity can be measured using pull-down or FRET-based assays to determine whether inhibitory signaling is engaged [1,3]. Dominant-negative constructs provide a complementary approach to test causality in vivo.
Transcriptional and expression profiling
RNA-seq and targeted expression analysis can identify transcriptional programs downstream of TIS7 and CRABP-II that enforce negative regulation of regenerative axon extension. Expression profiling also helps distinguish regenerative inhibition from developmental axon guidance.
In vivo nerve injury models
Sciatic nerve injury models allow direct testing of whether manipulating candidate genes enhances or impairs regeneration in vivo. These models can be combined with histological and functional readouts to quantify regenerative outcomes.
How CRISPR Can Be Used to Study GO:0048692 negative regulation of axon extension involved in regeneration
Knockout
CRISPR knockout of candidate negative regulators such as RhoA, Rac1, LINGO-1, or TIS7 can test whether loss of function enhances regenerative axon extension [1,3,7]. Knockout models are particularly useful for establishing causality in neurite outgrowth and in vivo regeneration assays.
Point Mutation
CRISPR point-mutation knock-in can be used to create kinase-dead or GTPase-dead variants, such as ACK1 kinase-dead or Rac1 mutants, to dissect domain-specific functions in regenerative inhibition [1,6]. These models help distinguish catalytic activity from scaffolding functions.
Knock-in
Knock-in of tagged or reporter alleles, such as fluorescently tagged RhoA or LINGO-1, enables live imaging of protein localization during regenerative axon extension [1,3]. Knock-in models can also introduce disease-relevant variants to study altered inhibitory signaling.
Overexpression
CRISPR-mediated overexpression or cDNA overexpression of negative regulators such as TIS7 or Nogo-A can confirm sufficiency in restricting regenerative axon extension [4,7]. Overexpression models are valuable for testing whether a candidate gene is sufficient to brake regeneration.
How EDITGENE Supports negative regulation of axon extension involved in regeneration Research
Researchers studying negative regulation of axon extension involved in regeneration-related genes often need to determine whether a candidate gene is causally involved in restraining regenerative growth or is merely correlated with it. CRISPR-based models provide the gold-standard approach to manipulate these genes precisely and test their function in neurons and injury models [1,3,6,7].
Contact EDITGENE today to design your custom CRISPR model for negative regulation of axon extension involved in regeneration research.
Frequently Asked Questions About negative regulation of axon extension involved in regeneration
What is GO:0048692?
GO:0048692 is the Gene Ontology biological_process term for negative regulation of axon extension involved in regeneration, defined as any process that stops, prevents, or reduces the frequency, rate or extent of axon extension involved in regeneration.
What genes are involved in negative regulation of axon extension involved in regeneration?
Key genes include RhoA, Rac1, Nogo-A, LINGO-1, ACK1, TIS7, and CRABP-II, based on experimental studies [1,3,4,6,7].
How does RhoA inhibit axon regeneration?
RhoA is a GTPase that restrains regenerative axon extension, and dominant-negative RhoA enhances sciatic nerve regeneration in vivo.
What is the role of Nogo-A in axon regeneration?
Nogo-A is a myelin-associated inhibitor that regulates neurite fasciculation, branching, and extension, and signals through LINGO-1 and Rho GTPases [3,4].
How is LINGO-1 involved in regenerative inhibition?
LINGO-1 is a co-receptor involved in Nogo-A-regulated differentiation of oligodendrocyte precursor cells through Rho GTPases.
What is the role of ACK1 in neuronal extension?
ACK1 is a tyrosine kinase that plays a role in neurotrophin signaling and neuronal extension and branching.
How does TIS7 regulate adult axon growth?
TIS7 is a transcriptional corepressor that regulates adult axon growth through cellular retinoic acid binding protein II (CRABP-II) expression.
Can CRISPR be used to study negative regulation of axon extension?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models can test causal roles of candidate genes in regenerative axon extension [1,3,6,7].
What diseases are linked to negative regulation of axon extension involved in regeneration?
Spinal cord injury, peripheral nerve injury, and neurodegenerative conditions are linked to this process [1,3,4,5].
What methods are used to study GO:0048692?
Neurite outgrowth assays, Rho GTPase activity assays, RNA-seq, immunofluorescence imaging, and in vivo nerve injury models are commonly used [1,3,6,7].
Conclusion
GO:0048692, negative regulation of axon extension involved in regeneration, defines the active cellular brakes that limit regenerative axon growth. Experimental evidence implicates RhoA, Rac1, Nogo-A, LINGO-1, ACK1, and TIS7 in this process, with direct relevance to spinal cord injury, peripheral nerve repair, and neurodegeneration [1,3,4,6,7]. CRISPR-based knockout, point-mutation, knock-in, and overexpression models are essential tools for causally dissecting these mechanisms and identifying therapeutic targets.
References
- 1. Kusano K et al.. 2011. Enhancement of sciatic nerve regeneration by adenovirus-mediated expression of dominant negative RhoA and Rac1.. Neurosci Lett 492(1):64-9 PMID: 21281699
- 2. Tang L et al.. 2021. Effects and molecular mechanisms of Achyranthes bidentata polypeptide k on proliferation of Schwann cells.. Ann Transl Med 9(20):1581 PMID: 34790787
- 3. Zhao XH et al.. 2007. An in vitro study on the involvement of LINGO-1 and Rho GTPases in Nogo-A regulated differentiation of oligodendrocyte precursor cells.. Mol Cell Neurosci 36(2):260-9 PMID: 17719796
- 4. Petrinovic MM et al.. 2010. Neuronal Nogo-A regulates neurite fasciculation, branching and extension in the developing nervous system.. Development 137(15):2539-50 PMID: 20573699
- 5. Viel C et al.. 2026. The Effects of Neurotropic B Vitamins, Vitamin D3, and Alpha-Lipoic Acid in In Vitro Models of Neurodegeneration.. Nutrients 18(15) PMID: 42588179
- 6. La Torre A et al.. 2013. A role for the tyrosine kinase ACK1 in neurotrophin signaling and neuronal extension and branching.. Cell Death Dis 4(4):e602 PMID: 23598414
- 7. Dieplinger B et al.. 2007. The transcriptional corepressor TPA-inducible sequence 7 regulates adult axon growth through cellular retinoic acid binding protein II expression.. Eur J Neurosci 26(12):3358-67 PMID: 18052984
